Skip to main content
Equibles

Parkman Healthcare Partners LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1777015 STAMFORD, CT
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,306,071
+$14,392,843 QoQ
Shares Held
1,377,576
+146.9% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
2.63%
of 13F equity value
Holder Rank
#28
of 215 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. VRDN ranks #5 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MBX
MBX Biosciences, Inc.
 800,173 $44,169,549
2 PTCT
Ptc Therapeutics, Inc.
 435,691 $35,539,314
3 RCUS
Arcus Biosciences, Inc.
 919,266 $28,340,970
4 GPCR
Structure Therapeutics Inc.
 485,661 $26,065,425
5 VRDN
Viridian Therapeutics, Inc.\DE
This page 		1,377,576 $25,306,071
6 AGIO
Agios Pharmaceuticals, Inc.
 669,046 $24,828,297
7 INBX
Inhibrx Biosciences, Inc.
 256,950 $24,346,012
8 XENE
Xenon Pharmaceuticals Inc.
 397,379 $23,985,796

All Filings in VRDN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,306,071 1,377,576
2026-03-31 $10,913,228 557,936
2025-12-31 $24,524,925 788,076
2025-09-30 $24,913,829 1,154,487
2025-06-30 $18,157,573 1,298,825
2025-03-31 $14,349,540 1,064,506
2024-12-31 $20,849,943 1,087,634
2024-09-30 $9,668,750 425,000
2022-09-30 $725,192 35,358